{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:49:34Z","timestamp":1791200974374,"version":"4.2.0"},"reference-count":46,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2014,4,3]],"date-time":"2014-04-03T00:00:00Z","timestamp":1396483200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J of Inher Metab Disea"],"published-print":{"date-parts":[[2014,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The monoamine neurotransmitter disorders are increasingly recognized as an expanding group of inherited neurometabolic syndromes caused by disturbances in the synthesis, transport and metabolism of the biogenic amines, including the catecholamines (dopamine, norepinephrine, and epinephrine) and serotonin. Disturbances in monoamine metabolism lead to neurological syndromes that frequently mimic other conditions, such as hypoxic ischemic encephalopathy, cerebral palsy, parkinsonism\u2010dystonia syndromes, primary genetic dystonia and paroxysmal disorders. As a consequence, neurotransmitter disorders are frequently misdiagnosed. Early and accurate diagnosis of these neurotransmitter disorders is important, as many are highly amenable to, and some even cured by, therapeutic intervention. In this review, we highlight recent advances in the field, particularly the recent extensive characterization of known neurotransmitter disorders and identification of novel neurotransmitter disorders. We also provide an overview of current and future research in the field focused on developing novel treatment strategies.<\/jats:p>","DOI":"10.1007\/s10545-014-9697-4","type":"journal-article","created":{"date-parts":[[2014,4,2]],"date-time":"2014-04-02T22:41:18Z","timestamp":1396478478000},"page":"619-626","source":"Crossref","is-referenced-by-count":47,"title":["What is new for monoamine neurotransmitter disorders?"],"prefix":"10.1002","volume":"37","author":[{"given":"Clara","family":"Marecos","sequence":"first","affiliation":[{"name":"Department of Neurology Great Ormond Street Hospital for Children NHS Foundation Trust London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Ng","sequence":"additional","affiliation":[{"name":"Department of Neurology Great Ormond Street Hospital for Children NHS Foundation Trust London UK"},{"name":"Developmental Neurosciences, UCL\u2010Institute of Child Health, Room 111 Level 1 CMGU Institute of Child Health 30 Guilford Street London WC1N 1EH UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manju A.","family":"Kurian","sequence":"additional","affiliation":[{"name":"Department of Neurology Great Ormond Street Hospital for Children NHS Foundation Trust London UK"},{"name":"Developmental Neurosciences, UCL\u2010Institute of Child Health, Room 111 Level 1 CMGU Institute of Child Health 30 Guilford Street London WC1N 1EH UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,4,3]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2009.01.010"},{"key":"e_1_2_5_3_1","first-page":"1455","article-title":"Infantile parkinsonism\u2010dystonia: a dopamine \u201ctransportopathy\u201d","volume":"119","author":"Blackstone C","year":"2009","journal-title":"J Clin Invest"},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(10)70280-5"},{"key":"e_1_2_5_5_1","doi-asserted-by":"publisher","DOI":"10.1086\/321970"},{"key":"e_1_2_5_6_1","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/47.3.477"},{"key":"e_1_2_5_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/humu.21529"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181e620ae"},{"key":"e_1_2_5_9_1","unstructured":"CawelloWKimSRBraunMElshoffJPIkedaJFunakiTPharmacokinetics safety and tolerability of rotigotine transdermal patch in healthy Japanese and Caucasian subjectsClin Drug Investig20133899448"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.1529"},{"key":"e_1_2_5_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20055"},{"key":"e_1_2_5_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2011.11.012"},{"key":"e_1_2_5_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-010-9200-9"},{"key":"e_1_2_5_14_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000312381.29287.ff"},{"key":"e_1_2_5_15_1","doi-asserted-by":"crossref","unstructured":"EspayAJ ChenR(2013)Myoclonus.Continuum (Minneap Minn) 19 (5 Movement Disorders):1264\u201386.","DOI":"10.1212\/01.CON.0000436156.54532.1a"},{"key":"e_1_2_5_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12098-009-0138-6"},{"key":"e_1_2_5_17_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000247274.21261.b4"},{"key":"e_1_2_5_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.22685"},{"key":"e_1_2_5_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mito.2008.05.001"},{"key":"e_1_2_5_20_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-991151"},{"key":"e_1_2_5_21_1","volume-title":"Atypical dopamine transporter deficiency syndrome in two adult males with molecular characterisation of new transporter variants","author":"Henriksen FH","year":"2012"},{"key":"e_1_2_5_22_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3003640"},{"key":"e_1_2_5_23_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.42.10.1980"},{"key":"e_1_2_5_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/dmcn.12130"},{"key":"e_1_2_5_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(11)70141-7"},{"key":"e_1_2_5_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(10)70269-6"},{"issue":"6","key":"e_1_2_5_27_1","first-page":"1595","article-title":"Homozygous loss\u2010of\u2010function mutations in the gene encoding the dopamine transporter are associated with infantile parkinsonism\u2010dystonia","volume":"119","author":"Kurian MA","year":"2009","journal-title":"J Clin Invest"},{"key":"e_1_2_5_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpn.2008.03.008"},{"key":"e_1_2_5_29_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000437299.51312.5f"},{"key":"e_1_2_5_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2011.10.001"},{"key":"e_1_2_5_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.25303"},{"key":"e_1_2_5_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/dmcn.12116"},{"key":"e_1_2_5_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2011.08.009"},{"key":"e_1_2_5_34_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awh603"},{"issue":"1","key":"e_1_2_5_35_1","first-page":"15","article-title":"TH gene\u2010negative infantile onset severe dopamine deficiency syndrome: a novel neurotransmitter disorder?","volume":"5","author":"Ng J","year":"2013","journal-title":"Dev Med Child Neurol"},{"key":"e_1_2_5_36_1","doi-asserted-by":"crossref","unstructured":"NgJ ZhenJ MeyerEet al. (2014)Dopamine transporter deficiency syndrome: phenotypic spectrum from infancy to adulthood.Brain. doi:10.1093\/brain\/awu022","DOI":"10.1093\/brain\/awu022"},{"key":"e_1_2_5_37_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.62.7.1058"},{"key":"e_1_2_5_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.25382"},{"key":"e_1_2_5_39_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1207281"},{"key":"e_1_2_5_40_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e318261714a"},{"key":"e_1_2_5_41_1","unstructured":"SwobodaK FurukawaY(2008)Tyrosine hydroxylase deficiency.GeneReviewsTM. Retrieved fromhttp:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1437\/in December 2013"},{"key":"e_1_2_5_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2007.04.006"},{"key":"e_1_2_5_43_1","doi-asserted-by":"publisher","DOI":"10.3171\/2011.3.PEDS10402"},{"key":"e_1_2_5_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2008.04.003"},{"key":"e_1_2_5_45_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awq087"},{"key":"e_1_2_5_46_1","doi-asserted-by":"publisher","DOI":"10.1177\/0883073810377014"},{"key":"e_1_2_5_47_1","doi-asserted-by":"publisher","DOI":"10.1006\/mgme.2001.3273"}],"container-title":["Journal of Inherited Metabolic Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1007\/s10545-014-9697-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T05:18:42Z","timestamp":1694755122000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1007\/s10545-014-9697-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,3]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["10.1007\/s10545-014-9697-4"],"URL":"https:\/\/doi.org\/10.1007\/s10545-014-9697-4","archive":["Portico"],"relation":{},"ISSN":["0141-8955","1573-2665"],"issn-type":[{"value":"0141-8955","type":"print"},{"value":"1573-2665","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,3]]}}}